Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA

• DOI: 10.57264/cer-2023-0186
• Publication Date: 2024-05-02T18:36:42Z
• Authors: May Hagiwara; Victoria Divino; Swapna Munnangi; Mark Delegge; Suna Park; Ed G Marins; Kaili Ren; Charlie Strange
• Keywords: Alpha 1-antitrypsin deficiency; Liver disease; Alpha (finance); Resource use

To evaluate all-cause and liver-associated healthcare resource utilization (HCRU) costs among patients with alpha-1 antitrypsin deficiency (AATD) liver disease (LD) and/or lung (LgD).